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Background: Styrene is an important building-block petrochemical and monomer used to produce numerous
plastics. Whereas styrene bioproduction by Escherichia coli was previously reported, the long-term potential of this
approach will ultimately rely on the use of hosts with improved industrial phenotypes, such as the yeast
Saccharomyces cerevisiae.
Results: Classical metabolic evolution was first applied to isolate a mutant capable of phenylalanine over-
production to 357 mg/L. Transcription analysis revealed up-regulation of several phenylalanine biosynthesis pathway
genes including ARO3, encoding the bottleneck enzyme DAHP synthase. To catalyze the first pathway step,
phenylalanine ammonia lyase encoded by PAL2 from A. thaliana was constitutively expressed from a high copy
plasmid. The final pathway step, phenylacrylate decarboxylase, was catalyzed by the native FDC1. Expression of
FDC1 was naturally induced by trans-cinnamate, the pathway intermediate and its substrate, at levels sufficient for
ensuring flux through the pathway. Deletion of ARO10 to eliminate the competing Ehrlich pathway and expression
of a feedback-resistant DAHP synthase encoded by ARO4K229L preserved and promoted the endogenous availability
precursor phenylalanine, leading to improved pathway flux and styrene production. These systematic improvements
allowed styrene titers to ultimately reach 29 mg/L at a glucose yield of 1.44 mg/g, a 60% improvement over the
initial strain.
Conclusions: The potential of S. cerevisiae as a host for renewable styrene production has been demonstrated.
Significant strain improvements, however, will ultimately be needed to achieve economical production levels.
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Similar to most other monomers used in conventional
plastics production, at present, styrene is derived exclu-
sively from non-renewable feedstocks. More specifically,
current styrene production predominantly involves the
energy-intensive chemocatalytic dehydrogenation of
petroleum-derived ethylbenzene [1,2]. With the global
annual demand of styrene expected to surpass 41 million
tons by 2020 [3], representing a > $28 billion U.S. market
[4], net energy requirements associated with just this
single conversion will amount to over 200 trillion BTU
of steam each year [5]. Accordingly, concerns over* Correspondence: David.R.Nielsen@asu.edu
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unless otherwise stated.depleting feedstock availability and deleterious environ-
mental impacts, continue to drive interest in developing
‘green’ processes for producing biorenewable replace-
ments to conventional petrochemicals, including mono-
mers such as styrene.
Advances in metabolic and pathway engineering con-
tinue to expand the range of conventional monomer
compounds that can be synthesized from renewable bio-
mass feedstocks [6-9]. Along these lines, the engineering
of a novel and non-natural pathway for styrene biosyn-
thesis from biomass-derived glucose was recently re-
ported using the bacterium Escherichia coli as host [10].
Said pathway, which is illustrated in Figure 1, utilizes en-
dogenous phenylalanine as its immediate precursor.
Phenylalanine is first deaminated to trans-cinnamate by
phenylalanine ammonia lyase (PAL), encoded by PAL2al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Styrene biosynthesis by engineered S. cerevisiae. Dashed arrows signify multiple steps are involved but not illustrated. Black arrows
represent enzymes steps native to S. cerevisiae whereas gray arrows are heterologous; dotted arrows represent multiple enzymatic steps;
feedback repression is shown using thin dotted lines with flat heads whereas transcriptional activation is shown using thin dotted lines with a
round head and ‘+’; disruption of a gene or regulatory mechanism is signified by ‘X’. Abbreviations: phosphoenolpyruvate (PEP), erythrose-4-
phosphate (E-4P), 3-deoxy-D-arabino-heptulosonate-7-phosphate (DAHP), hydroxyphenylpyruvate (HPP), 2-phenylacetaldehyde (PAA).
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decarboxylated to styrene via phenylacrylate decarboxyl-
ase, encoded by FDC1 from Saccharomyces cerevisiae
[10,11]. Co-expressing PAL2 and FDC1 in a previously-
engineered phenylalanine over-producing E. coli back-
ground resulted in styrene titers as high as ~260 mg/L
(2.5 mM) in glucose minimal media after 29 h, repre-
senting a glucose yield of ~0.07 g/g (0.12 mol/mol; 25%
of theoretical) [10]. As a commodity chemical, however,
said production metrics must be improved for biologic-
ally derived styrene to emerge as a viable alternative to
its conventional counterpart [12].
The engineering of more robust hosts for renewable
chemical production is an important aim in industrialbiotechnology [13] and, relative to E. coli, yeast biosyn-
thetic platforms often afford several inherent attributes
of importance to robust and large–scale renewable che-
micals production. Said phenotypes most significantly
include faster growth rates, elevated solvent tolerance,
and the ability to withstand low temperatures and pH
[14-18]. Amongst yeast, S. cerevisiae is a particularly at-
tractive host for metabolic engineering efforts owing to
its well characterized genetics, physiology, and metabol-
ism, as well as due to the availability of diverse genetic
toolkits for its engineering [19]. Past studies have dem-
onstrated that S. cerevisiae is a suitable host for the re-
newable production of useful aromatic compounds,
including protocatechuate, catechol, vanillin, naringenin,
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however, has not yet been reported.
The objective of the present study was to demonstrate
that styrene biosynthesis from glucose could be system-
atically engineered in S. cerevisiae. In addition to the
aforementioned phenotypic advantages afforded by the
use of S. cerevisiae, this aim was further motivated by
other relevant factors. For instance, it was hypothesized
that improved function of styrene pathway enzymes
might be realized in S. cerevisiae since: i) PAL2 is of
eukaryotic origin, and ii) FDC1 is native to S. cerevisiae.
Furthermore, contingent upon the native regulation of
FDC1 expression (as investigated in this study), it is
plausible that a functional styrene pathway could be
constructed by expressing a single heterologous enzyme
(i.e., PAL2), thereby minimizing the effects of metabolic
burden. Meanwhile, as S. cerevisiae lacks a natural trans-
porter for phenylalanine efflux [24], it was hypothesized
that increased intracellular retention of phenylalanine
might enhance its availability to the engineered pathway.
These unique features position S. cerevisiae as particu-
larly promising host for renewable styrene production.
In this study, classical anti-metabolite selection was first
applied to evolve a S. cerevisiae strain capable of over-
producing phenylalanine, the styrene pathway precursor.
Rational genetic engineering approaches were used to
construct the non-natural styrene pathway and further
boost precursor availability. While not before applied for
styrene bioproduction, this basic approach has beenFigure 2 Evolution of phenylalanine overproducing mutants of S. cere
and high-throughput selection on solid agar plates using m-fluoro-DL-phen
phenylacetate (hashed) production by isolated mutants was determined af
phenylethanol and 2-phenylacetate in the supernatant. Error bars reportedproven effective for engineering bacterial producers of
other aromatic chemicals [25-28].
Results and discussion
Evolving phenylalanine over-production by S. cerevisiae
As phenylalanine serves as the immediate endogenous
precursor to the styrene pathway, its over-production
by S. cerevisiae is an essential pre-requisite to styrene
biosynthesis. Thus, to develop a phenylalanine over-
production phenotype in S. cerevisiae, a classic anti-
metabolite selection strategy was first employed [29]. In
this case, m-fluoro-DL-phenylalanine was chosen to pro-
vide the necessary selection pressure whereas exposure
to the chemomutagen EMS increased mutation rates
and frequency [30]. In the first round of selection, a total
of only two mutants were isolated when using either
18 mg/L (strain 18A) or 22 mg/L (strain 22A) m-fluoro-
DL-phenylalanine. As seen in Figure 2, said mutants
were subsequently characterized in shake flask cultures.
Since phenylalanine is not exported from S. cerevisiae,
the established practice of correlating enhanced flux
through the pathway with net extracellular accumulation
of 2-phenylethanol and 2-phenylacetate (both of which
are naturally and readily produced as degradation prod-
ucts of phenylpyruvate, the precursor to phenylalanine;
Figure 1) was employed [24]. In S. cerevisiae, it has pre-
viously been shown that all available phenylalanine is ef-
ficiently shuttled through one or both of these pathways
[31], with the relative distribution of products beingvisiae. Mutants were evolved through the use of EMS mutagenesis
ylalanine as anti-metabolite. 2-Phenylethanol (gray) and 2-
ter 48 h of growth in SD media by measuring the concentration of 2-
at one standard deviation from triplicate experiments.
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intracellular ratio of NAD + to NADH) [32]. For ex-
ample, in glucose grown cultures with limited aeration
(as would be expected in the sealed shake flasks used in
this study), 9:1 mixtures of 2-phenylethanol:2-phenylace-
tate are typically observed [32]. Throughout this study,
the mixture of products obtained was similarly consist-
ent (an average of 89% 2-phenylethanol; Figure 2). Rela-
tive to BY4741 (the parent strain and control), strains
18A and 22A showed 3.3- and 6.4-fold improvements in
net production of 2-phenylethanol and 2-phenylacetate
(0.63 ± 0.05 and 1.13 ± 0.10 mM), respectively.
To further deregulate and enhance phenylalanine bio-
synthesis, a second round of mutagenesis and selection
was performed, in this case using the isolated mutants
18A and 22A as parents. The selection pressure was ac-
cordingly elevated by increasing the content of m-
fluoro-DL-phenylalanine in SD agar plates to 25 mg/L,
50 mg/L, or 75 mg/L. In contrast to the first round, in
this case numerous colonies (i.e., > 50) were obtained at
all three selection pressures. Thus, to screen just for the
best performers, only the fastest growing mutants were
selected (i.e., those whose colony forming units were lar-
gest after overnight incubation). A total of 18 additional
mutants were chosen and subsequently characterized, as
above. As seen in Figure 2, the top performing mutant,
22A75D, produced a combined total of about 2.17 ±
0.22 mM 2-phenylethanol and 2-phenylacetate in 48 h,
representing ~3.3- and ~21-fold improvements over 22A
and BY4741, respectively.
Investigating the evolved phenotypes
A series of characterizations were next performed on
strains 22A and 22A75D (with BY4741 as control) to
begin to understand the underlying factors responsible
for imparting the evolved phenotypes. The native aro-
matic amino acid biosynthesis pathways of S. cerevisiae
are shown in Figure 1, where it can be seen that two
known control points are principally responsible regulat-
ing metabolite flux. The first occurs at DAHP synthase
(for which S. cerevisiae possesses two isoenzymes),
which is allosterically feedback inhibited by either
phenylalanine (ARO3) or tyrosine (ARO4) [33-35]. The
second, meanwhile, occurs at chorismate mutase
(ARO7), which converts chorismate to prephenate, the
precursor to both phenylalanine and tyrosine. Transcrip-
tion of ARO7 is repressed in the presence of as little as
0.5 mM tyrosine but remains, however, insensitive to
phenylalanine [33,36,37]. Here, overcoming feedback re-
pression of ARO3 thus constitutes a key priority. How-
ever, whereas relief from tyrosine repression of ARO4
has been reported to result from a single mutation
(K229L) [24], a phenylalanine feedback resistant mutant
of ARO3 remains unreported to date.Sequences of several key genes in the phenylalanine
biosynthesis pathway (ARO3, ARO4, ARO7, ARO8, and
PHA2) were first determined for all three strains (includ-
ing coding regions as well as 500 bp upstream of each
start codon). Interestingly, however, mutations were not
observed in the sequence of any investigated gene, in-
cluding with respect to both its coding and upstream
non-coding regions. Transcription levels of all genes in
the phenylalanine biosynthesis pathway (namely ARO1,
ARO2, ARO3, ARO4, ARO7, ARO8, ARO9, and PHA2;
see Figure 1) were next examined in the mutants 22A
and 22A75D and quantified relative to that of the wild-
type control (BY4741). The results are compared in
Figure 3, wherein it can be seen that, in strain 22A75D,
up-regulation of ARO8 was found to be most significant
(a 9.3-fold increase), followed by ARO1 (6.8-fold), ARO2
(5.8-fold), and ARO3 (4.5-fold). Note that similar but
less significant differences were also observed in strain
22A. Furthermore, only modest increases in ARO4 and
ARO7 expression were observed in 22A75D (about 2.7-
and 1.8-fold, respectively), with no significant changes
occurring in 22A for either gene.
The collective findings point to the prospects of sev-
eral interesting mechanisms in the mutant strains. For
example, with no change to its sequence, the evolved
phenotype clearly did not arise as a result of relieving
allosteric inhibition at the known bottleneck enzyme,
ARO3. However, as a significant increase in its expres-
sion was observed in both mutants, this could suggest
that up-regulation of wild type ARO3 occurred as an al-
ternative strategy. That is, despite the fact that the wild
type enzyme possesses lower specific activity in the pres-
ence of phenylalanine, with more copies net DAHP syn-
thase activity may have been sufficiently high so as to
effectively overcome the flux bottleneck. Simultaneous
up-regulation of ARO1 and ARO2 (the two subsequent
steps in the pathway), meanwhile, may have aided in this
process by ensuring that produced DAHP was then
promptly assimilated further along the pathway, thereby
maintaining a maximum driving force. Up-regulated ex-
pression of ARO1 has been successfully employed in
yeast as a rational approach for enhancing the biosyn-
thesis of cis,cis-muconic acid – a product derived from
the shikimate pathway intermediate 3-hydroshikimate
[38]. Meanwhile, up-regulation of ARO8 was evolved
perhaps as a mechanism to compete with the native ac-
tivity of ARO10, ensuring that metabolite flux was effi-
ciently routed towards phenylalanine biosynthesis rather
than through the degradative Ehrlich pathway [32,39].
This prospect is further supported by the fact that, in
contrast to ARO8, no appreciable change was observed
with respect to the expression of ARO9, which functions
primarily in the reverse direction (i.e., for phenylalanine
assimilation from the culture medium) [40].
Figure 3 Transcriptional analysis of top phenylalanine overproducing S. cerevisiae mutants. Relative transcript levels of the top first (22A)
and second (22A75D) round evolved yeast mutants, normalized to the parent (BY4741). Measured genes included ARO1 (black), ARO2 (right
diagonal), ARO3 (dark gray), ARO4 (horizontal), ARO7 (light gray), ARO8 (left diagonal), ARO9 (no fill), and PHA2 (hashed). Error bars reported at one
standard deviation from triplicate experiments.
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coding regions for any of the four up-regulated genes
(ARO1, ARO2, ARO3, and ARO8) another factor must
be responsible for this observed result. Increased copy
number through genomic amplifications is one possibil-
ity, however, a more efficient mechanism may have in-
volved the mutation of one or more transcription factors
controlling their expression. GCN4 encodes one such
major transcription factor [41], however, further sequen-
cing revealed no changes there either. To identify other
prospective transcription factors involved, the promoter
regions of the four up-regulated genes were further in-
vestigated by aligning the 1000 bp sequences prior to
each start codon. Whereas a possible consensus se-
quence of 5’-AACATC-3’ was located at positions −292,
−307, −289, and −290 for ARO1, ARO2, ARO3, and
ARO8, respectively, said sequence does not match bind-
ing site of any known transcription factor. Among all
known transcriptional regulators, eleven are shared be-
tween the four up-regulated genes [42] (note, an anno-
tated list is provided in Additional file 1: Table S3). The
ability to determine which if any of these regulators are
responsible for the evolved changes will only be possible
through the collective analysis of their gene sequences,
or better, to ensure full elucidation of all changes in the
mutants, through whole-genome sequencing. However,
given that the achievable titers are still quite modest
(a total of only 2.17 ± 0.22 mM 2-phenylethanol and 2-phenylacetate), such an undertaking was deemed as un-
warranted at this time. For now, and for the purpose of
this study, these efforts were successful in developing a
host strain to serve as a test platform for engineering
styrene biosynthesis from glucose.
Investigating native FDC1 activity and factors influencing
its expression
Although it had previously been shown that, when cul-
tured in the presence of exogenous trans-cinnamate, S.
cerevisiae is capable of catalyzing its decarboxylation to
styrene [11], several factors related to the native function
and expression of FDC1 remained initially unclear and
deserving of further investigation. Most importantly, it
was wholly unknown as to if, when, and how the native
expression of FDC1 would be induced in the context of
the styrene pathway and under the culture conditions of
interest. BY4741 was initially cultured in SD minimal
media supplemented with potential inducers of interest.
In addition to trans-cinnamate and phenylalanine (the
pathway intermediate and precursor, respectively), p-
coumarate and ferulate were also screened as positive
controls (note, both are structural homologs of trans-
cinnamate and known inducers of trans-cinnamate de-
carboxylase activity [11]). As seen in Table 1, in vitro
trans-cinnamate decarboxylase activity was detected in
the lysates of cells cultured in the presence of each of
trans-cinnamate, p-coumarate, and ferulate (with the
Table 1 Assaying the in vitro decarboxylase activity of
FDC1 against a pool of structurally-related, phenylacrylic
acid substrates
Compound Induced activity mU mg−1 total protein
trans-cinnamate + 0.46 ± 0.02
p-coumarate + 0.39 ± 0.02
ferulate + 0.21 ± 0.03
phenylalanine - N.D.
none (control) - N.D.
Positive, ‘+’; Negative, ‘-‘; Not Detected, ‘N.D.’.
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phenylalanine or in the control. With respect to the styr-
ene pathway, this implies that native FDC1 expression
will be wholly contingent upon the heterologous expres-
sion of PAL2 to provide trans-cinnamate as inducer
(a realization that could be of benefit with respect to
minimizing overall metabolic burden).Evaluating the styrene pathway via the exogenous
addition of phenylalanine
Preliminary studies were next performed to begin probing
the functionality of the styrene pathway in wild type S. cere-
visiae. Strains BY4741-PAL and BY4741ΔFDC1-PAL were
first cultured in SD-Leu minimal media supplemented with
200 mg/L (1.21 mM) phenylalanine while monitoring the
extracellular accumulation of trans-cinnamate, styrene, andFigure 4 Assessing the trans-membrane export of trans-cinnamate. D
growing cultures of wild-type S. cerevisiae BY4741-PAL and BY4741ΔFDC1-P
(horizontal), and 2-phenylethanol (gray) after 24 h. Error bars reported at on2-phenylethanol, 2-phenylacetate, and concomitant deple-
tion of phenylalanine. As seen in Figure 4, while only 37%
of supplied the phenylalanine was consumed by BY4741-
PAL after 24 h, styrene and 2-phenylethanol constituted
the major end-products, reaching titers of up to 20 ± 1 and
43 ± 1 mg/L (0.19 ± 0.01 and 0.35 ± 0.01 mM), respectively,
with trans-cinnamate being undetected. In contrast, 2-
phenylethanol was produced to a final titer of 98 ± 3 mg/L
(0.80 ± 0.02 mM) by BY4741ΔFDC1-PAL with styrene be-
ing undetected throughout. In addition, in this case the
extracellular accumulation of trans-cinnamate was also ob-
served, reaching final concentration of 26 ± 3 mg/L (0.18 ±
0.02 mM) by 24 h. Only trace levels of 2-phenylacetate
were observed throughout.
These results demonstrate several key points. First,
styrene can be produced from phenylalanine by S.
cerevisiae via the heterologous expression of PAL2
and native expression of FDC1. Second, both styrene
and trans-cinnamate are naturally excreted from S.
cerevisiae, at least to a certain degree. Third, since
trans-cinnamate did not accumulate in BY4741-PAL
cultures, this implies that the net activity afforded by
native FDC1 expression was sufficiently high so as to
preclude the creation of a flux bottleneck at the final
pathway step (at least with respect to the specific
PAL2 expression level examined). And, lastly, that
under the conditions examined, synthesis of bypro-
duct 2-phenylethanol significantly competes with the
styrene pathway for precursor availability, even whenepletion of exogenous phenylalanine (black; initially 200 mg/L) by
AL and the resultant production of trans-cinnamate (diagonal), styrene
e standard deviation from triplicate experiments.
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ber plasmid.
Styrene production from glucose
Based on the above findings, a series of strains were next
constructed and evaluated with respect to their styrene
production potential from glucose, the results of which
are compared in Figure 5. Although only as much as
~5 mg/L (0.05 mM) styrene was detected in BY4741-
PAL cultures, 22A75D-PAL accumulated up to 18 ±
2 mg/L (0.17 ± 0.02 mM) styrene in 48 h. In the latter
culture, however, more significant accumulation of bypro-
duct 2-phenylethanol was also observed, reaching up to
54 ± 5 mg/L (0.44 ± 0.04 mM; again, 2-phenylacetate did
not accumulate above trace levels). As this again suggested
that the native Ehrlich pathway was competitively inhibit-
ing the styrene pathway with respect to precursor avail-
ability, the effect of deleting ARO10 – which converts
phenylpyruvate to phenylacetaldehyde [32,43] – on styr-
ene production was explored. As seen in Figure 5, deletion
of ARO10 to preserve phenylpyruvate availability im-
proved styrene production by 22A75D10-PAL by ~28%,
reaching up to 23 ± 2 mg/L (0.22 ± 0.02 mM). Lastly, to
further improve styrene production, a feedback resistant
mutant of ARO4 – namely ARO4K229L – was introduced
into 22A75D10-PAL. Although ARO4 encodes a tyrosine-
sensitive DAHP synthase, in previous works ARO4K229L
over-expression in S. cerevisiae was shown to increase flux
through the shikimic acid pathway by as much as 4.5-fold
[16,24]. Here, expressing ARO4K229L, 22A75D104-PALFigure 5 Styrene biosynthesis from glucose by engineered S. cerevisia
strains BY4741-PAL, 22A75D-PAL, 22A75D10-PAL, and 22A75D104-PAL after
reported at one standard deviation from triplicate experiments.displayed an additional 25% increase in styrene titer,
reaching up to 29 ± 2 mg/L (0.28 ± 0.02 mM) at a glucose
yield of about 1.44 ± 0.11 mg/g (0.0025 ± 0.0002 mol/mol;
or just 0.6% of theoretical). Meanwhile, trans-cinnamate
was not detected in the culture media of any styrene pro-
ducing strain at any time (data not shown).
As a volatile product, it was also noted that styrene
significantly accumulated within the headspace of each
sealed flask. We have previously confirmed that said
vapor–liquid partitioning behaves according to Henry’s
Law, with a dimensionless Henry’s Law coefficient of
0.113 at 32°C [10]. For the conditions examined here,
this meant that an additional ~45% styrene was pro-
duced and accumulated in each case. With this in mind,
the maximum volumetric styrene production achieved
here would be more accurately represented as 42 ±
3 mg/L (0.40 ± 0.03 mM) with a glucose yield of 2.09 ±
0.16 mg/g (0.0036 ± 0.0003 mol/mol; 0.9% of theoret-
ical). The volatile nature of styrene may also prove use-
ful as a product recovery strategy in the future [44].
Even at this adjusted output, however, achievable styr-
ene production remains only 18% of the net production
of 2-phenylethanol and 2-phenylacetate demonstrated by
22A75D (2.17 ± 0.22 mM) and is 65% of the net produc-
tion of styrene and 2-phenylethanol by 22A75D-PAL
(0.61 ± 0.02 mM). This suggests that multiple limiting
factors may have arisen during strain construction. Al-
though it was not anticipated to be problematic at such
low aqueous titers, to ensure that end-product inhibition
was not the central productivity-limiting factor, ae strains. Styrene (gray) and 2-phenylethanol (lined) production by
48 h in SD-Leu minimal media in sealed shake flask cultures. Error bars
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cerevisiae growth and viability was found to be only
minimally disrupted in the presence of styrene at up to
at least 200 mg/L (1.92 mM; data not shown), suggesting
that styrene toxicity was not a critical barrier at this
point. Over-expression of PAL2 appears to have had the
greatest negative impact, reducing net aromatic produc-
tion by 72%. This was likely due to the metabolic burden
imposed by its expression from a high-copy plasmid.
While decreasing PAL2 expression will likely reduce bur-
den, as trans-cinnamate was never detected in styrene
producing cultures, this already points to the fact that
PAL2 activity was rate-limiting in the styrene pathway.
Thus, future and careful optimization of PAL2 expres-
sion and/or the identification of other PAL homologs
displaying greater inherent activity in S. cerevisiae will
be key to achieving further improvements in styrene
production.
Lastly, although seemingly low, it should be appreci-
ated that level of styrene production demonstrated here
agrees well with that of prior reports by others whom
have engineered S. cerevisiae to produce aromatic che-
micals (for which Curran et al. previously provided a
comprehensive examination). Notable examples include
p-hydroxycinnamate [45], p-aminobenzoic acid [46], p-
hydroxybenzoic acid [46], and vanillin [20], which have
been produced to maximal titers of up to 33.3, 34.3,
89.8, and 45 mg/L, respectively, at yields of 1.7, 2.3, 6.0,
and 2.3 mg/g. Meanwhile, when compared with the
baseline for styrene production established using an E.
coli platform [10], the achievable titers and yields dem-
onstrated with S. cerevisiae currently lag by about 9- and
21-fold, respectively. To achieve higher styrene titers
with S. cerevisiae, further de-regulation of metabolite
flux through its phenylalanine biosynthesis pathway will
ultimately be required.
Conclusions
By coupling the classical approach of metabolic evolu-
tion with systematic strain and pathway engineering,
styrene bioproduction directly from glucose by S. cerevi-
siae has been demonstrated for the first time. While pro-
viding an important demonstration of concept, future
strain engineering efforts will be required to ultimately
achieve economical production levels.
Materials and methods
Strains and media
All strains and plasmids used in this study are listed in
Table 2. Custom oligonucleotide primers were synthe-
sized by Integrated DNA Technologies (Coralville, IA)
and are provided in Additional file 1: Table S1. All S. cer-
evisiae strains were purchased from Thermo Scientific
(Waltham, MA). Yeast plasmids used were derived fromthe Gateway vector collection and purchased from
AddGene (Cambridge, MA). Genomic DNA was pre-
pared from S. cerevisiae whole cells using the ZR Fun-
gal/Bacterial DNA MiniPrep (Zymo Research, Irvine,
CA) according to vendor protocols. E. coli strain
NEB10β (New England Biolabs, Ipswich, MA) was used
for routine cloning and plasmid propagation, except for
pDONR221 which was propagated in One Shot ccdB
Survival 2 T1 E. coli (Life Technologies, Grand Island,
NY). E. coli strains were routinely cultured at 37°C in
Luria-Bertani (LB) broth supplemented with appropriate
antibiotics, as necessary. Yeast strains were routinely
cultured at 32°C in Yeast Extract Peptone Dextrose
(YPD) medium, yeast synthetic dextrose (SD) medium,
or yeast synthetic minimal (SD-Leu) medium. YPD
medium was composed of 10 g/L yeast extract, 20 g/L
peptone, and 20 g/L glucose. SD medium was composed
of 6.7 g/L yeast nitrogen base, 20 g/L glucose, and
20 mg/L of each uracil, histidine, leucine, and methio-
nine. SD-Leu medium was composed of 6.7 g/L yeast ni-
trogen base, 20 g/L glucose, 20 mg/L each uracil,
histidine, and methionine.
Evolution of phenylalanine over-producing mutants
Evolution of a phenylalanine over-producing phenotype
in S. cerevisiae was achieved through random mutagen-
esis and high-throughput selection. The phenylalanine
anti-metabolite m-fluoro-DL-phenylalanine provided se-
lective pressure. S. cerevisiae BY4741 was first treated
with ethylmethanesulphonate (EMS) according to stand-
ard protocols [47] before then being plated on minimal
media supplemented with m-fluoro-DL-phenylalanine.
In the first round of mutagenesis, selection occurred on
SD media plates supplemented with either 18 or 22 mg/
Lm-fluoro-DL-phenylalanine. Note that the minimum
inhibitory concentration of m-fluoro-DL-phenylalanine
against BY4741 was initially determined as ~15 mg/L
(data not shown). Mutants isolated from the first round
were then subjected to a second round of mutagenesis
and selection, however, in this case using 25, 50, or
75 mg/Lm-fluoro-DL-phenylalanine. All isolated mu-
tants were then cultured in SD media at 32°C for 48 h
and periodically sampled and analyzed by high perform-
ance liquid chromatography (HPLC; as described below)
to assess their comparative abilities with respect to pro-
ducing 2-phenylethanol and 2-phenylacetate. Note that
2-phenylethanol and phenylacetate, which are endogen-
ously produced from phenylpyruvate via ARO10 and ei-
ther a native alcohol dehydrogenase (i.e., ADH1-6, and
others putative dehydrogenases) or phenylacetaldehyde
dehydrogenase (i.e., ALD1-6), respectively, were collect-
ively used as surrogates to indicate enhanced flux
through the phenylalanine biosynthesis pathway due to
the fact that phenylalanine is not naturally exported by
Table 2 List of strains and plasmids engineered and/or used in this study
Strain Genotype Source
E. coli
NEB10β araD139 Δ(ara,leu)7697 fhuA lacX74 galK16 galE15 mcrA f80d(lacZΔM15)recA1 relA1 endA1 nupG rpsL rph
spoT1Δ(mrr-hsdRMS-mcrBC)
New England
Biolabs
One Shot ccdB Survival
2 T1
F−mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 araΔ139 Δ(ara-leu)7697galU galK rpsL (StrR)
endA1 nupG fhuA::IS2
Life
Technologies
S. cerevisiae
BY4741 MATa his3Δ0 leu2Δ0 met15Δ0 ura3Δ0 Thermo Scientific
BY4741ΔFDC1
(YDR539W)
MATa his3Δ0 leu2Δ0 met15Δ0 ura3Δ0 fdc1Δ Thermo Scientific
22A phenylalanine overproducer evolved from BY4741 This Study
22A75D phenylalanine overproducer evolved from 22A This Study
BY4741-PAL MATa his3Δ0 leu2Δ0 met15Δ0 ura3Δ0 p425GPDPAL This Study
BY4741ΔFDC1-PAL MATa his3Δ0 leu2Δ0 met15Δ0 ura3Δ0 fdc1Δ p425GPDPAL This Study
22A75D-PAL 22A75D harboring p425GPDPAL This Study
22A75D10-PAL 22A75D aro10Δ harboring p425GPDPAL This Study
22A75D104-PAL 22A75D aro10Δ::aro4K229L harboring p425GPDPAL This Study
Plasmids
pTrc99A Ptrc, pBR322 ori, lacI
q, AmpR Prather Lab, MIT
pFA6-KanMX KanR2, pBR322 ori, AmpR AddGene
pDONR221 attP1-ccdB-CmR-attP2 cassette, pUC ori, KanR Life
Technologies
pDONR-PAL PAL2 from A. thaliana inserted into pDONR221 This study
p425GPD PGPD, attR1-ccdB-Cm
R-attR2 cassette, pBR322 ori, LEU2, AmpR AddGene
p425GPDPAL PAL2 from A. thaliana inserted into p425GPD This study
pACYCDuet-1 PT7lac, p15A ori, lacI
q, CmR Novagen
pACYC-ARO4K229L-
KanMX
pACYCDuet-1 with the integration cassette aro4K229L-KanMX This Study
pUN15-PAL2 Clone U12256 containing AT3G53260 (PAL2) from A. thaliana ABRC
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way and regulatory genes (specifically, ARO3, ARO4,
ARO7, ARO8, GCN4, and PHA2) were sequenced in
each of BY4741 (wild type control) and top evolved mu-
tants. In all cases, both the entire coding regions as well
as 500 bp upstream of the start codon were sequenced.
Transcriptional analysis of phenylalanine over-producing
mutants
Relative transcription levels of each of ARO1, ARO2,
ARO3, ARO4, ARO7, ARO8, ARO9, and PHA2 were
quantified at mid-log phase in each of BY4741 and the
evolved mutants 22A and 22A75D. Approximately 1.5 ×
108 cells of each of strain were collected by centrifuga-
tion at 17,000 x g for 1 min. The supernatant was dis-
carded and RNA was extracted from the cell pellet using
the YeaStar RNA Extraction Kit (Zymo Research, Irvine,
CA). cDNA was synthesized using the SuperScript VILO
cDNA Synthesis Kit (Life Technologies) whereas RT-qPCR
was performed using SYBR Green (Life Technologies)based quantitative PCR according to manufacturer’s proto-
cols. Custom oligonucleotide primers for RT-qPCR experi-
ments, including those for the reference housekeeping gene
26S [48], were designed and synthesized, the sequences of
which are provided in Additional file 1: Table S2. RT-qPCR
was performed on an Applied Biosystems StepOne Real-
Time PCR (Applied Biosystems) using a 60°C annealing
temperature. Data analysis was performed using StepOne
software with relative transcriptional levels calculated via
the 2-ΔΔCt method [49].
Investigating native induction and activity of FDC1
A seed culture of S. cerevisiae BY4741 were prepared in
5 mL YPD broth at 32°C while shaking at 250 rpm over-
night. The same seed (1 mL) was then used to inoculate
a series of sealed shake flasks (250 mL) each containing
50 ml SD media. Cultures were grown until reaching an
OD600 of ~0.6, at which point either trans-cinnamate,
ferulate, p-coumarate, or phenylalanine were added to a
final concentration of 0.2 mM. All cultures were
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number of cells (~7.4x107) were collected by centrifuga-
tion at 2,800 x g for 4 min. The cell pellet was lysed
using Zymolyase (Zymo Research) before the sample
was then centrifuged at 11,000 x g for 2 min to separate
and collect the supernatant. Each sample was then
assayed for its ability to catalyze the decarboxylation of
trans-cinnamate to styrene by adding 5 μL of crude cell
lysate to a 1 mL solution of 50 mM Tris–HCl buffer
(pH 7.5) initially containing 250 mM trans-cinnamate.
All samples were incubated at room temperature with
the subsequent accumulation of styrene in the reaction
mixture then followed at 247 nm for a total of 5 min at
20 s intervals using a UV/Vis spectrophotometer. A
molar extinction coefficient of 10,000 M−1 cm−1 [50]
and a 1 cm path length were used to establish activity in
terms of mU mg−1 total protein. Total protein content
in crude lysates was determined by Bradford Assay using
bovine serum albumin (BSA) as an external standard.
Cloning of PAL2 from A. thaliana
The PAL2 encoding gene from A. thaliana was derived
from a cDNA library plasmid containing the specific loci
of interest (AT3G53260) and obtained from the Arabi-
dopsis Biological Research Center (ABRC; Ohio State
University, Columbus, OH). PAL2 was PCR amplified
using Phusion DNA Polymerase (Finnzymes, Espoo,
Finland) and custom oligonucleotide primers (Additional
file 1: Table S1). Using Gateway Cloning Technology [19],
amplified linear DNA fragments flanked with attB se-
quences were purified using the Zyppy Clean and Concen-
trator kit (Zymo Research). The BP reaction between the
DNA fragment and pDONR221 (Life Technologies) was
performed using Gateway BP Clonase II Enzyme Mix (Life
Technologies) following manufacturer’s protocols. Trans-
formations were performed using chemically competent
NEB10β with transformants being selected by plating over-
night on LB solid agar containing 34 mg/L kanamycin. The
resultant donor plasmid, pDONR-PAL, was mixed with the
desired destination plasmid, p425GPD, using the Gateway
LR Clonase II Enzyme Mix (Life Technologies), with trans-
formation and selection as previously performed. As listed
in Table 2, this approach resulted in construction of
p425GPDPAL, a high copy (2 μ) plasmid for the constitu-
tive expression of PAL2 in S. cerevisiae.
Assaying the extracellular transport potential of trans-
cinnamate
S. cerevisiae BY4741 and the FDC1 deletion mutant
BY4741ΔFDC1 were each transformed with plasmid
p425GPDPAL, resulting in strains BY4741-PAL and
BY4741ΔFDC1-PAL, respectively. All yeast transforma-
tions were performed by lithium acetate method [51].
Both strains were then cultured in SD-Leu media. Uponreaching OD600 of ~0.6, 200 mg/L phenylalanine was
then added to each culture, after which the extracellular
accumulation of each of trans-cinnamate, styrene, and
2-phenylethanol were then periodically monitored via
HPLC for a total period of 24 h.
Chromosomal disruption of ARO10 and integration of
ARO4K229L
Targeted chromosomal disruption of ARO10 in strain
22A75D was performed via homologous recombination.
Gene disruption cassettes were generated via PCR to
contain 40 base pairs of homology on both sides of the
targeted integration site (i.e., ARO10), in addition to the
KanMX selectable marker (as obtained from pFA6-
KanMX4). Following transformation, colonies were se-
lected on YPD solid agar plates containing 200 mg/
L G418. Clones successfully carrying the ARO10 disrup-
tion cassette were further confirmed by colony PCR.
This resulted in the strain 22A75D10. In addition, a copy
of the feedback resistant mutant ARO4K229L, whose ex-
pression was driven by the native ARO4 promoter, was
likewise integrated into 22A75D at the ARO10 locus,
thereby also and simultaneously resulting in the
chromosomal disruption of ARO10. In this case, how-
ever, the gene disruption cassette was first constructed
in the E. coli expression vector pACYCDuet-1. The
ARO4 point mutation (K229L) was generated via overlap
extension using primers as listed in Additional file 1:
Table S1. The resultant fragment containing ARO4K229L
was inserted between the BamHI and EcoRI sites of
pACYCDuet-1, before the desired mutation was then
confirmed by sequencing. Subsequently, the KanMX se-
lectable marker with its promoter was PCR amplified
from pFA6-KanMX4 before then being inserted down-
stream of ARO4K229L to generate the plasmid pACYC-
ARO4K229L-KanMX. The entire cassette was then PCR
amplified using primers whose overhangs each contained
40 base pairs of homology to ARO10. The resultant frag-
ment was then transformed into 22A74D, followed by
selection on YPD solid agar plates containing 200 mg/
L G418. Successful clones were further confirmed by
colony PCR, resulting in strain 22A75D104.
Styrene production from glucose by S. cerevisiae
S. cerevisiae BY4741, 22A75D, 22A75D10, and 22A75D104
were each individually transformed with the plasmid
p425GPDPAL. The resultant strains (BY4741-PAL, 22A75D-
PAL, 22A75D10-PAL, and 22A75D104-PAL, respectively)
were then each grown in 5 mL SD-Leu broth for 12 h at
32°C while shaking at 250 rpm to prepare seed cultures.
Each seed (1 mL) was then used to inoculate 50 mL SD-Leu
media in a 250 ml shake flask sealed with a glass cap. A
closed system with large headspace was used to avoid volatile
product (i.e., styrene) losses while also precluding the
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periodic sampling performed to determine cell growth, re-
sidual substrate levels, and metabolite production.
HPLC analysis
Substrate and metabolite concentrations were deter-
mined via HPLC analysis. Samples were prepared by first
removing 1 mL of culture from shake flasks and pellet-
ing the cells at 11,000 x g for 2 min. The supernatant
(0.75 mL) was then transferred to a glass HPLC vial
which was then sealed with a Teflon-lined screw cap.
Separation and analysis was performed using a Hewlett
Packard 1100 series HPLC system (Palo Alto, CA)
equipped with an auto sampler, diode array (UV/Vis) de-
tector, and reverse-phase Hypersil Gold SBC18 column
(4.6 mm x 150 mm; Thermo Fisher, USA), according to
previously described methods [10]. The eluent was moni-
tored at 215 nm for phenylalanine, 2-phenylethanol, and
2-phenylacetate, and at 258 nm for trans-cinnamate and
styrene. Using the same HPLC system, glucose analysis
was performed using an RID detector and an anion ex-
change column (Aminex HPX-87H; BioRAD, Hercules,
CA). The column was eluted with 0.005 M H2SO4 at a
constant flow rate of 0.8 ml/min.
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